Literature DB >> 7530720

Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor.

P A Weernink1, G Rijksen.   

Abstract

We have examined the subcellular distribution and catalytic activity of c-Src tyrosine kinase after stimulation of A172 glioblastoma cells with peptide growth factors. Treatment of resting cells with platelet-derived growth factor resulted in an increase (3.5-fold) in the amount of c-Src protein associated with the cytoskeleton. In addition, an increase in specific c-Src kinase activity was observed in the cytoskeleton as well as in the cytosol and the membrane fraction. Similar effects on both c-Src redistribution and activity were seen after stimulation with epidermal growth factor. These data show that, like other signal transducing components, c-Src also becomes activated and associated to the cytoskeleton in response to growth factor stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530720     DOI: 10.1074/jbc.270.5.2264

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.

Authors:  T Goi; M Shipitsin; Z Lu; D A Foster; S G Klinz; L A Feig
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

2.  Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.

Authors:  Mary E Irwin; Natacha Bohin; Julie L Boerner
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

3.  Regulation of Yin Yang 1 by Tyrosine Phosphorylation.

Authors:  Gary Z Wang; Stephen P Goff
Journal:  J Biol Chem       Date:  2015-07-21       Impact factor: 5.157

4.  Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors.

Authors:  Jing Bao; Gal Gur; Yosef Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 5.  An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer.

Authors:  Ahmed M Elshazly; David A Gewirtz
Journal:  Cancer Drug Resist       Date:  2022-06-01

6.  Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.

Authors:  Chen-Hong Li; Qi Zhang; Bunyen Teng; S Jamal Mustafa; Jian-Ying Huang; Han-Gang Yu
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-31       Impact factor: 4.249

7.  Dissecting motility signaling through activation of specific Src-effector complexes.

Authors:  Andrei V Karginov; Denis Tsygankov; Matthew Berginski; Pei-Hsuan Chu; Evan D Trudeau; Jason J Yi; Shawn Gomez; Timothy C Elston; Klaus M Hahn
Journal:  Nat Chem Biol       Date:  2014-03-09       Impact factor: 15.040

8.  Distinctive subcellular inhibition of cytokine-induced SRC by salubrinal and fluid flow.

Authors:  Qiaoqiao Wan; Wenxiao Xu; Jing-long Yan; Hiroki Yokota; Sungsoo Na
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

9.  Mutation of the SRC gene in endometrial carcinoma.

Authors:  M Sugimura; K Kobayashi; S Sagae; Y Nishioka; S Ishioka; K Terasawa; T Tokino; R Kudo
Journal:  Jpn J Cancer Res       Date:  2000-04

10.  TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells.

Authors:  D-W Wu; T-C Chen; H-S Huang; H Lee
Journal:  Cell Death Dis       Date:  2016-06-30       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.